Market News & Analysis
Exxon CEO exits as production lags
Ken Odeluga December 14, 2016 8:01 PM
A friend of Vladimir
Nobody likes to think they won’t be missed.
But if you’re the CEO of the biggest oil company in the world and the shares rise after investors hear you’re on the way out, perhaps that’s just one of those things. Not that Exxon Mobil CEO Rex Tillerson, on Tuesday nominated as U.S. Secretary of State by President-elect Donald Trump, will care. The 64-year old Texan reportedly has a personal style to match his gnarly looks.
Having been deeply involved with Exxon when deals were forged or recast with almost every oil crude producing nation in the world, an appropriate one-word description of Tillerson might be “tough”. He’ll need to be. Trouble’s already brewing on the Senate Foreign Relations Committee which must approve his nomination. Sen. Marco Rubio, the former Republican nomination hopeful, who sits on it tweeted: “Being a “friend of Vladimir” is not an attribute I am hoping for”, from Sec. of State.
Links may run deep enough to attract the scrutiny of an intelligence arm that already made clear its suspicions over the influence of Russia’s president on the U.S. elections. And calls are getting louder on The Capitol for a probe into whether Putin actively plotted to help Trump win. Still, a few minutes of research are all it takes to discover that no Presidential nomination or President-elect pick for Secretary of State has ever been denied by the Senate.
Chances of rejection are further reduced by the Senate’s Republican dominance and Tillerson’s solid reputation in the corporate world. So why the mild celebration by shareholders? XOM closed almost 2% higher on Tuesday, though is giving back slightly more as I write this a day later. Well, apart from investor hopes that some tacit influence or facilitation might find its way back to Exxon from its former boss, other shareholders have clearly been restive of late.
Exxon production ex-growth
The group’s late effort to join the shale boom saw it pay $39bn, a price widely regarded as a high premium, for XTO Energy in 2009, with just 5 further years of strong oil prices before values collapsed.
On the legal front, the U.S. Securities and Exchange Commission is investigating how Exxon accounts for its oil and gas reserves and communicates with investors about climate change. Regardless of whether the regulator demands that Exxon restate its reserves, the group has warned it might cut crude reserves reported in its books by nearly 20% if the recent oil price surge reverses.
More recently, investors have compared Exxon’s production growth against rivals and found the U.S. supermajor wanting, particularly with oil up 45% this year. Reuters data shows Exxon production up 2.3% between 2015 fiscal year end and 2016 third quarter end, whilst ConocoPhillips and Shell grew theirs 3%-5%.
Plus, Shell is forecast to pump 20% more oil in the current fiscal year, whilst Exxon’s rate is seen flat. Royal Dutch is the key rival to watch we think after its humongous purchase of BG Group catapulted it into Exxon’s league and Shell’s CEO threw down the gauntlet by stating he wanted to beat the U.S. group’s shareholder returns.
Whilst Exxon’s average return against enterprise value has been some 7 percentage points above Shell’s on average over five years, Shell has recently caught up. It has notched a 2.77% return on invested capital so far this year vs. Exxon’s 2%.
Exxon’s sluggish output growth and narrowing lead on returns versus its rival partly account for its marked stock underperformance compared to Shell this year. The Anglo-Dutch group’s stock is up 39% in 2016 against Exxon’s 17%.
Investors might be hoping for better under Exxon’s likely next CEO Darren Woods. But the world remains just as uncertain since Tillerson’s exit, perhaps more so, under a Donald Trump Presidency.
In our view, Exxon also looks less favoured on a technical-chart basis from a medium term-perspective, regardless of the undeniable uptrend of oil prices and in the stock itself. XOM now has a first test of the ‘failure’ high of November 2015 under its belt and at the same time is trading above the crucial 61.8% retracement of its July 2014-August 2015 decline. However, it is telling that two major price gaps have appeared in price action within months of each other (late July and this week) and neither have been filled. Instead of soaking up liquidity left hanging when prices slid as much as 5% on 29th July, on Monday 12th December, the stock vaulted orders between $89.61-$89.01 and in fact widened the prior range of unfilled orders to anything between $90.14-$89.
As we know price gaps are usually–though not always–filled, representing the tendency of more ‘steadfast money’ to keep market orders open, particularly if prospects of retracement look good. We think the chances are more than fair in this case. If that proves an accurate forecast, Exxon shares will soon trade back below the 61.8% market ($90.08) which will then turn from implied support to a resistance.
At the same time it’s worth noting that early this week, Exxon stock had seldom looked more overbought in years (judging by the extent of protuberance of the Relative Strength Index beyond the indicator’s ’70′ upper bound).
The overall technical picture would have to deteriorate significantly to reverse the current uptrend in the shares, though in line with our outline of the current fundamentals above, we expect the stock to be challenged over the longer term if Exxon fails to address a poor recent performance against close rivals.
Please click image to enlarge
More From Ken Odeluga
- US techs back at Club 1999 April 28, 2017 4:43 PM
- Why Barclays is now weakest big bank stock in Europe April 28, 2017 11:18 AM
- See More
From time to time, GAIN Capital Limited’s (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.